Transplanted mesenchymal stromal cells are unable to migrate to the bone surface and subsequently improve osteogenesis in glucocorticoid-induced osteoporosis

Zaidi, 2007, Skeletal remodeling in health and disease, Nat Med, 13, 791, 10.1038/nm1593 Hadjidakis, 2006, Bone remodeling, Ann N Y Acad Sci, 1092, 385, 10.1196/annals.1365.035 Manolagas, 1995, Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 Yao, 2013, Reversing bone loss by directing mesenchymal stem cells to bone, Stem Cells, 31, 2003, 10.1002/stem.1461 Guan, 2012, Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass, Nat Med, 18, 456, 10.1038/nm.2665 Tang, 2009, TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation, Nat Med, 15, 757, 10.1038/nm.1979 Erlebacher, 1998, Osteoblastic responses to TGF-beta during bone remodeling, Mol Biol Cell, 9, 1903, 10.1091/mbc.9.7.1903 Alliston, 2001, TGF-beta–induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation, EMBO J, 20, 2254, 10.1093/emboj/20.9.2254 Maeda, 2004, Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells, EMBO J, 23, 552, 10.1038/sj.emboj.7600067 Halleux, 2001, Multi-lineage potential of human mesenchymal stem cells following clonal expansion, J Musculoskelet Neuronal Interact, 2, 71 Chen, 2007, Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts, J Bone Miner Res, 22, 1943, 10.1359/jbmr.070725 Engler, 2006, Matrix elasticity directs stem cell lineage specification, Cell, 126, 677, 10.1016/j.cell.2006.06.044 Zhang, 2017, Effect of matrix stiffness on osteoblast functionalization, Cell Prolif, 50, e12338, 10.1111/cpr.12338 Dallas, 2002, Proteolysis of latent transforming growth factor-beta (TGFbeta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGFbeta from bone matrix, J Biol Chem, 277, 21352, 10.1074/jbc.M111663200 Ota, 2013, Transforming growth factor beta1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors, Bone, 57, 68, 10.1016/j.bone.2013.07.023 Dallas, 1995, Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein, J Cell Biol, 131, 539, 10.1083/jcb.131.2.539 Chandra, 2021, Skeletal aging and osteoporosis: mechanisms and therapeutics, Int J Mol Sci, 22, 3553, 10.3390/ijms22073553 Almeida, 2017, Estrogens and androgens in skeletal physiology and pathophysiology, Physiol Rev, 97, 135, 10.1152/physrev.00033.2015 Rauch, 2010, Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor, Cell Metab, 11, 517, 10.1016/j.cmet.2010.05.005 Li, 2013, Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation, Cell Death Dis, 4, e832, 10.1038/cddis.2013.348 Bikle, 2003, The impact of skeletal unloading on bone formation, Gravit Space Biol Bull, 16, 45 Khosla, 2017, Osteoporosis treatment: recent developments and ongoing challenges, Lancet Diabetes Endocrinol, 5, 898, 10.1016/S2213-8587(17)30188-2 Rachner, 2011, Osteoporosis: now and the future, Lancet, 377, 1276, 10.1016/S0140-6736(10)62349-5 Jiang, 2021, Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis, Cell Prolif, 54, e12956, 10.1111/cpr.12956 Kiernan, 2017, Concise review: musculoskeletal stem cells to treat age-related osteoporosis, Stem Cells Transl Med, 6, 1930, 10.1002/sctm.17-0054 Sui, 2019, Stem cell-based regeneration in diseased microenvironments: challenges and solutions, Biomaterials, 196, 18, 10.1016/j.biomaterials.2017.10.046 Su, 2018, Mesenchymal stem cell migration during bone formation and bone diseases therapy, Int J Mol Sci, 19, 2343, 10.3390/ijms19082343 Li, 2015, The role of bone marrow microenvironment in governing the balance between osteoblastogenesis and adipogenesis, Aging Dis, 7, 514, 10.14336/AD.2015.1206 Zhang, 2016, Effect of TGF-β1/SDF-1/CXCR4 signal on BM-MSCs homing in rat heart of ischemia/perfusion injury, Eur Rev Med Pharmacol Sci, 20, 899 Rath, 2016, Evidence of an interaction between TGF-β1 and SDF1/CXCR4/CXCR7 axis in human platelets, Thromb Res, 144, 79, 10.1016/j.thromres.2016.06.006 Halder, 2005, A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers, Neoplasia, 7, 509, 10.1593/neo.04640 Black, 2016, Clinical practice. Postmenopausal osteoporosis, N Engl J Med, 374, 254, 10.1056/NEJMcp1513724 Cosman, 2009, Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates, Endocr Pract, 15, 483, 10.4158/EP08306.ORR1 Akesson, 2003, New approaches to pharmacological treatment of osteoporosis, Bull World Health Organ, 81, 657 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Oh, 2021, Mesenchymal stromal cells for the treatment of ocular autoimmune diseases, Prog Retin Eye Res, 85, 10.1016/j.preteyeres.2021.100967 Götherström, 2020, Stem cell therapy as a treatment for osteogenesis imperfecta, Curr Osteoporos Res, 18, 337, 10.1007/s11914-020-00594-3 Langrzyk, 2018, Critical view on mesenchymal stromal cells in regenerative medicine, Antioxid Redox Signal, 29, 169, 10.1089/ars.2017.7159 Yagi, 2010, Mesenchymal stem cells: mechanisms of immunomodulation and homing, Cell Transplant, 19, 667, 10.3727/096368910X508762 Lien, 2009, Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells, J Bone Miner Res, 24, 837, 10.1359/jbmr.081257 Sui, 2016, Allogeneic mesenchymal stem cell therapy promotes osteoblastogenesis and prevents glucocorticoid-induced osteoporosis, Stem Cell Translational Medicine, 5, 1238, 10.5966/sctm.2015-0347 Becker, 2016, Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy?, World J Stem Cells, 26, 73, 10.4252/wjsc.v8.i3.73 Fischer, 2009, Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect, Stem Cells Dev, 18, 683, 10.1089/scd.2008.0253 Fabian, 2017, Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health, Stem Cell Res Ther, 8, 85, 10.1186/s13287-017-0533-2 Zheng, 2021, The elevated level of IL-1α in the bone marrow of aged mice leads to MSC senescence partly by down-regulating Bmi-1, Exp Gerontol, 148, 10.1016/j.exger.2021.111313 Valenti, 2016, Osteogenic differentiation in healthy and pathological conditions, Int J Mol Sci, 18, 41, 10.3390/ijms18010041 Tikhonova, 2019, The bone marrow microenvironment at single-cell resolution, Nature, 569, 222, 10.1038/s41586-019-1104-8 Shen, 2021, A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis, Nature, 591, 438, 10.1038/s41586-021-03298-5 Sanghani-Kerai, 2017, Osteoporosis and ageing affects the migration of stem cells and this is ameliorated by transfection with CXCR4, Bone Joint Res, 6, 358, 10.1302/2046-3758.66.BJR-2016-0259.R1 Haasters, 2014, Mesenchymal stem cells from osteoporotic patients reveal reduced migration and invasion upon stimulation with BMP-2 or BMP-7, Biochem Biophys Res Commun, 452, 118, 10.1016/j.bbrc.2014.08.055 Nikolaou, 2009, The influence of osteoporosis in femoral fracture healing time, Injury, 40, 663, 10.1016/j.injury.2008.10.035 Pfeilschifter, 2002, Changes in Proinflammatory cytokine activity after menopause, Endocr Rev, 23, 90, 10.1210/edrv.23.1.0456